| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |